Products
Applications
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Products
System
Panels
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Sample Integrity
Specimen Validity
Hereditary Genetics
Methylation
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Products
System
Panels
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Sample Integrity
Specimen Validity
Hereditary Genetics
Methylation
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Liquid Biopsy
Search All publications
How recent?
Search
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study
Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
A Micro-Costing Framework for Circulating Tumor DNA testing In Dutch Clinical Practice
Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study – a multicentre prospective observational cohort study
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer
Recent Developments in Mutation Enrichment and Detection Technologies
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors
1
2
3
4
5
...
»